Your browser doesn't support javascript.
loading
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics.
Little, Robert D; Ward, Mark G; Wright, Emily; Jois, Asha J; Boussioutas, Alex; Hold, Georgina L; Gibson, Peter R; Sparrow, Miles P.
Affiliation
  • Little RD; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
  • Ward MG; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
  • Wright E; Department of Gastroenterology, St. Vincent's Hospital, Melbourne University, Melbourne 3004, Australia.
  • Jois AJ; Department of Gastroenterology & Clinical Nutrition, Royal Children's Hospital, Melbourne 3052, Australia.
  • Boussioutas A; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
  • Hold GL; Microbiome Research Centre, St. George Hospital, University of New South Wales, Sydney 2217, Australia.
  • Gibson PR; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
  • Sparrow MP; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
J Clin Med ; 11(20)2022 Oct 19.
Article in En | MEDLINE | ID: mdl-36294494
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Suiza